The Claim
The SLC2A9 gene encodes a protein that functions as a high-capacity urate transporter in human metabolism, in addition to its previously characterized role as a fructose transporter.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
The SLC2A9 gene produces a protein that moves urate in human cells, and it also moves fructose. This means it has two known roles in how the body handles these substances.
See the scientific wording
The SLC2A9 gene, previously characterized as a fructose transporter, also functions as a high-capacity urate transporter, expanding its known physiological role in human metabolism.
A protein made by the SLC2A9 gene pulls uric acid from the blood into kidney cells, where it gets recycled back into the bloodstream instead of being flushed out in urine. When this protein works less well due to genetic differences, more uric acid leaves the body in urine, lowering blood levels and reducing the chance of painful joint crystals.
What the research says
1 studyThis gene was already known to help move fructose into cells, but this study found it also moves uric acid — a waste product — which means it does double duty in the body. That’s why people with certain versions of this gene have more uric acid in their blood and are more likely to get gout.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.